<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[protein genetics inc. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/protein+genetics+inc..html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to protein genetics inc.]]></description>
	<s:counts start="0" returned="9" found="9" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Viral Genetics Announces Licensing Deal With University of Colorado and V-Clip Pharmaceuticals, Inc.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200712/ai_n21170974]]></link>
		<description><![CDATA[Viral Genetics, Inc. (PINKSHEETS: VRAL), a biotechnology company that discovers and develops immune-based therapies for HIV and AIDS using its thymus nuclear protein ("TNP") compound, has entered into several agreements with the University of Colorado and V-Clip Pharmaceuticals, Inc. relating to the exclusive worldwide rights to patent applications and know-how...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 20 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+colorado.html"><![CDATA[University of Colorado]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Sembiosys Signs Pact For Cangene Plant-Produced Insulin]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0DHC/is_1_19/ai_n16912608]]></link>
		<description><![CDATA[CSemBioSys Genetics Inc. (TSX:SBS), Calgary, a biotechnology company developing a broad pipeline of protein-based pharmaceuticals and non-pharmaceutical products, has completed a Technology Transfer and Manufacturing Agreement with Cangene Corporation, a biopharmaceutical company and contract manufacturing organization, for the processing and purification of SemBioSys' plant-produced insulin. The contract is part of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Jan 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cangene+corp..html"><![CDATA[Cangene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CNJ</category>
		<category domain="tickers">CNJ</category>
	</item>
	<item>
		<title><![CDATA[SemBioSys Signs Contract Manufacturing Agreement for Plant-Produced Insulin With Cangene.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200611/ai_n23579319]]></link>
		<description><![CDATA[CALGARY, Canada, November 22 /PRNewswire/ --    - Canadian Biotechnology Company Secures Manufacturing Partner to  Supply Insulin in Preparation for Preclinical and Clinical Development    SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company  developing a  broad pipeline of protein-based pharmaceuticals and  non-pharmaceutical ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 22 Nov 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cangene+corp..html"><![CDATA[Cangene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CNJ</category>
		<category domain="tickers">CNJ</category>
	</item>
	<item>
		<title><![CDATA[ONEI, PPTI, RSTG, SSRV, XPNG have also been added to naked short lists today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200506/ai_n19874142]]></link>
		<description><![CDATA[M2 PRESSWIRE-30 June 2005-BUYINS.NET: ONEI, PPTI, RSTG, SSRV, XPNG  have also been added to naked short lists todayC1994-2005 M2  COMMUNICATIONS LTD    RDATE:30062005    BUYINS.NET, www.buyins.net, announced today that these select  companies have been added to the NASDAQ, AMEX and NYSE naked short...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 30 Jun 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/oneida+ltd..html"><![CDATA[Oneida Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/smartserv+online+inc..html"><![CDATA[SmartServ Online Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Interleukin Genetics Licenses Gene Variations That Are Associated with Body Weight Differences]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_June_28/ai_n6088081]]></link>
		<description><![CDATA[WALTHAM, Mass. -- Interleukin Genetics, Inc. (OTCBB:ILGN) reported today that it has signed an agreement with Tufts University for exclusive rights to develop and commercialize tests and nutritional products based on variations in the perilipin gene that have been associated with body weight differences.  Perilipin is a protein in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Jun 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/interleukin+genetics+inc..html"><![CDATA[Interleukin Genetics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/tufts+university.html"><![CDATA[Tufts University]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ILI</category>
		<category domain="tickers">ILI</category>
	</item>
	<item>
		<title><![CDATA[Researchers Link Common Gene Variations to Levels of Biomarker for Cardiovascular Disease, C-Reactive Protein]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_May_17/ai_85974113]]></link>
		<description><![CDATA[Business Editors & Health/Medical Writers  WALTHAM, Mass.--BW HealthWire--May 17, 2002  Genetic Predisposition to Exuberant Inflammatory Response  May Complement CRP as Early Risk Factor for Cardiovascular  and Other Inflammatory Diseases  Interleukin Genetics, Inc. (NASDAQ:ILGN) and researchers at the Mayo Clinic announced today findings from a clinical...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 17 May 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/c.html"><![CDATA[C]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/inflammation.html"><![CDATA[inflammation]]></category>
		<category domain="http://resources.bnet.com/topic/interleukin+genetics+inc..html"><![CDATA[Interleukin Genetics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ILI</category>
		<category domain="tickers">ILI</category>
	</item>
	<item>
		<title><![CDATA[Paradigm Genetics Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0UFV/is_9_15/ai_82272394]]></link>
		<description><![CDATA[* Paradigm Genetics Inc. (Nasdaq: PDGM) of Research Triangle Park has received its first U.S. Patent. Patent 6,303,365, titled "Method of determining activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5-phosphate synthase," is for a gene that produces a potential herbicide target protein. It was discovered jointly by Paradigm and Bayer AG of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 01 Dec 2001 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bayer+ag.html"><![CDATA[Bayer AG]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/germany.html"><![CDATA[Germany]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/protein.html"><![CDATA[protein]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAYR Y</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">BAYR Y,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Marine Genetics to buy Ampro in fish meal and oil consolidation.(American Proteins)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199711/ai_n13223968]]></link>
		<description><![CDATA[THE LARGEST US PROVIDER of fish meal and oil has bolstered its  presence with a new acquisition. Zapata Corporation's $120 million  Marine Genetics Corporation unit has added to its portfolio the US  fishing and production assets of American Proteins Inc.       Marine...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Nov 1997 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/chicago.html"><![CDATA[Chicago]]></category>
		<category domain="http://resources.bnet.com/topic/consolidation.html"><![CDATA[consolidation]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/protein.html"><![CDATA[protein]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+agriculture.html"><![CDATA[U.S. Department of Agriculture]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Sofamor Danek Announces Effectiveness Of Genetics Institute Agreement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1995_April_4/ai_16764164]]></link>
		<description><![CDATA[MEMPHIS, Tenn.--BUSINESS WIRE--April 4, 1995--Sofamor Danek Group, Inc. (NYSE:SDG) today announced that the agreement with Genetics Institute, Inc. for the commercialization of bone morphogenetic protein BMP for spinal reconstruction has become effective.  Effectiveness of the agreement was contingent upon routine Hart Scott Rodino review and that waiting period expired...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 04 Apr 1995 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/business+wire.html"><![CDATA[Business Wire]]></category>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
